Details for New Drug Application (NDA): 018704
✉ Email this page to a colleague
The generic ingredient in LOPRESSOR is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
Summary for 018704
Tradename: | LOPRESSOR |
Applicant: | Novartis |
Ingredient: | metoprolol tartrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Mar 30, 1984 | TE: | RLD: | Yes |
Expired US Patents for NDA 018704
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | LOPRESSOR | metoprolol tartrate | INJECTABLE;INJECTION | 018704-001 | Mar 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | LOPRESSOR | metoprolol tartrate | INJECTABLE;INJECTION | 018704-001 | Mar 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription